BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22068590)

  • 1. Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype.
    Pierson CR; Dulin-Smith AN; Durban AN; Marshall ML; Marshall JT; Snyder AD; Naiyer N; Gladman JT; Chandler DS; Lawlor MW; Buj-Bello A; Dowling JJ; Beggs AH
    Hum Mol Genet; 2012 Feb; 21(4):811-25. PubMed ID: 22068590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential muscle hypertrophy is associated with satellite cell numbers and Akt pathway activation following activin type IIB receptor inhibition in Mtm1 p.R69C mice.
    Lawlor MW; Viola MG; Meng H; Edelstein RV; Liu F; Yan K; Luna EJ; Lerch-Gaggl A; Hoffmann RG; Pierson CR; Buj-Bello A; Lachey JL; Pearsall S; Yang L; Hillard CJ; Beggs AH
    Am J Pathol; 2014 Jun; 184(6):1831-42. PubMed ID: 24726641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatase-dead myotubularin ameliorates X-linked centronuclear myopathy phenotypes in mice.
    Amoasii L; Bertazzi DL; Tronchère H; Hnia K; Chicanne G; Rinaldi B; Cowling BS; Ferry A; Klaholz B; Payrastre B; Laporte J; Friant S
    PLoS Genet; 2012; 8(10):e1002965. PubMed ID: 23071445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis.
    Buj-Bello A; Fougerousse F; Schwab Y; Messaddeq N; Spehner D; Pierson CR; Durand M; Kretz C; Danos O; Douar AM; Beggs AH; Schultz P; Montus M; Denèfle P; Mandel JL
    Hum Mol Genet; 2008 Jul; 17(14):2132-43. PubMed ID: 18434328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific Mtm1 mutagenesis by an AAV-Cre vector reveals that myotubularin is essential in adult muscle.
    Joubert R; Vignaud A; Le M; Moal C; Messaddeq N; Buj-Bello A
    Hum Mol Genet; 2013 May; 22(9):1856-66. PubMed ID: 23390130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice.
    Danièle N; Moal C; Julien L; Marinello M; Jamet T; Martin S; Vignaud A; Lawlor MW; Buj-Bello A
    J Neuropathol Exp Neurol; 2018 Apr; 77(4):282-295. PubMed ID: 29408998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPEG interacts with myotubularin, and its deficiency causes centronuclear myopathy with dilated cardiomyopathy.
    Agrawal PB; Pierson CR; Joshi M; Liu X; Ravenscroft G; Moghadaszadeh B; Talabere T; Viola M; Swanson LC; Haliloğlu G; Talim B; Yau KS; Allcock RJ; Laing NG; Perrella MA; Beggs AH
    Am J Hum Genet; 2014 Aug; 95(2):218-26. PubMed ID: 25087613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy.
    Lawlor MW; Armstrong D; Viola MG; Widrick JJ; Meng H; Grange RW; Childers MK; Hsu CP; O'Callaghan M; Pierson CR; Buj-Bello A; Beggs AH
    Hum Mol Genet; 2013 Apr; 22(8):1525-38. PubMed ID: 23307925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular, biochemical and molecular changes in muscles from patients with X-linked myotubular myopathy due to MTM1 mutations.
    Bachmann C; Jungbluth H; Muntoni F; Manzur AY; Zorzato F; Treves S
    Hum Mol Genet; 2017 Jan; 26(2):320-332. PubMed ID: 28007904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers.
    Beggs AH; Böhm J; Snead E; Kozlowski M; Maurer M; Minor K; Childers MK; Taylor SM; Hitte C; Mickelson JR; Guo LT; Mizisin AP; Buj-Bello A; Tiret L; Laporte J; Shelton GD
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14697-702. PubMed ID: 20682747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Study of a Cohort of X-Linked Myotubular Myopathy at the Clinical, Histologic, and Genetic Levels.
    Abath Neto O; Silva MR; Martins Cde A; Oliveira Ade S; Reed UC; Biancalana V; Pesquero JB; Laporte J; Zanoteli E
    Pediatr Neurol; 2016 May; 58():107-12. PubMed ID: 26995067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutation in MTM1 causes X-Linked myotubular myopathy in Boykin spaniels.
    Olby NJ; Friedenberg S; Meurs K; DeProspero D; Guevar J; Lau J; Yost O; Guo LT; Shelton GD
    Neuromuscul Disord; 2020 May; 30(5):353-359. PubMed ID: 32417001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-Linked Myotubular Myopathy in a Female Patient with a Pathogenic Variant in the
    Chausova P; Murtazina A; Stepanova A; Borovicov A; Kovalskaia V; Ryadninskaya N; Chukhrova A; Ryzhkova O; Poliakov A
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linked myotubular myopathy due to a complex rearrangement involving a duplication of MTM1 exon 10.
    Trump N; Cullup T; Verheij JB; Manzur A; Muntoni F; Abbs S; Jungbluth H
    Neuromuscul Disord; 2012 May; 22(5):384-8. PubMed ID: 22153990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic deep intronic MTM1 variant activates a pseudo-exon encoding a nonsense codon resulting in severe X-linked myotubular myopathy.
    Bryen SJ; Oates EC; Evesson FJ; Lu JK; Waddell LB; Joshi H; Ryan MM; Cummings BB; McLean CA; MacArthur DG; Kornberg AJ; Cooper ST
    Eur J Hum Genet; 2021 Jan; 29(1):61-66. PubMed ID: 32862205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Necklace" fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy.
    Bevilacqua JA; Bitoun M; Biancalana V; Oldfors A; Stoltenburg G; Claeys KG; Lacène E; Brochier G; Manéré L; Laforêt P; Eymard B; Guicheney P; Fardeau M; Romero NB
    Acta Neuropathol; 2009 Mar; 117(3):283-91. PubMed ID: 19084976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway.
    Blondeau F; Laporte J; Bodin S; Superti-Furga G; Payrastre B; Mandel JL
    Hum Mol Genet; 2000 Sep; 9(15):2223-9. PubMed ID: 11001925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of myotubularins in blood platelets: Characterization and potential diagnostic of X-linked myotubular myopathy.
    Mansour R; Severin S; Xuereb JM; Gratacap MP; Laporte J; Buj-Bello A; Tronchère H; Payrastre B
    Biochem Biophys Res Commun; 2016 Jul; 476(3):167-73. PubMed ID: 27155155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-linked myotubular myopathy mimics hereditary spastic paraplegia in two female manifesting carriers of pathogenic MTM1 variant.
    Kraatari M; Tuominen H; Tuupanen S; Haapaniemi T; Moilanen J; Rahikkala E
    Eur J Med Genet; 2020 Nov; 63(11):104040. PubMed ID: 32805447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-linked myotubular myopathy in a female infant caused by a new MTM1 gene mutation.
    Schara U; Kress W; Tücke J; Mortier W
    Neurology; 2003 Apr; 60(8):1363-5. PubMed ID: 12707446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.